BMAL1 and central nervous system cancer: Furthermore, CRY2 and PER2 would suppress glioma tumorigenesis by suppressing ETNK1 expression through the transcription factor NR4A2 or by suppressing C‐MYC or TP53 expression through the NPAS2‐BMAL1 complex (Figure 1B).